期刊文献+

2(1H)-喹啉酮类化合物的药理活性及构效关系 被引量:15

Pharmacological Activities and Structure-activity Relationship of 2(1H)-quinolinone Compounds
下载PDF
导出
摘要 列举若干具代表性的药物,从抗精神失常、抗血小板聚集、正性肌力、抗肿瘤、抗溃疡和抗过敏作用等几方面综述2(1H)-喹啉酮类化合物的药理活性及构效关系。 In terms of antipsychotolytic,antiplatelet, positive inotropic, antitumor, antiallergic and antiulcer, the pharmacological activities and structure-activity relationship of 2(1H)-quinolinone compounds were reviewed, citing a certain number of pharmacological representative drugs with title structure.
出处 《药学进展》 CAS 2005年第7期309-316,共8页 Progress in Pharmaceutical Sciences
关键词 2(1H)-喹啉酮 药理活性 构效关系 2(1H)-quinolinone Pharmacological activity Structure-activity relationship
  • 相关文献

参考文献31

  • 1马培奇.新型抗精神病药阿立哌唑及其市场展望[J].上海医药,2003,24(10):458-460. 被引量:12
  • 2Kikuchi T, Tottori K, Uwahodo Y, et al. OPC-14597, a new putative antipsychotic drug with both presynaptic dopamine autoreceptor agonistic activity and postsynaptic D2 receptor antagonistic activity[J]. J Pharmacol Exp Ther , 1995,274( 1 ): 329-336. 被引量:1
  • 3Oshiro Y, Sato S, Kurahashi N, et al. Novel antipsychotic agents with dopamine autoreceptor agonist properties: synthesis and pharmacology of 7- [ 4- ( 4- phenyl- 1- piperazinyl) butoxy ] 3, 4-dihydro-2 ( 1H)-quinolinone derivatives [ J ]. J Med Chem, 1998,41(5) :658-667. 被引量:1
  • 4ZhaoH, ThurkaufA, Braun J, etal. Design, synthesis, and discovery of 3-piperazinyl- 3,4-dihydro-2 ( 1H)-quinolinone derivatives: a novel series of mixed dopamine D2/D4 receptor antagonists[J]. Bioorg Med Chem Lett , 2000,10(18):2119-2122. 被引量:1
  • 5Oshiro Y, Sakurai Y, Sato S, et al. 3,4-dihydro-2(1H)quinolinone as a novel antidepressant drug: synthesis and pharmacology of 1-[ 3-[ 4-( 3-chlorophenyl )-1-piperazinyl ]propyl]-3, 4-dihydro-5-methoxy-2 ( 1H )-quinolinone and its derivatives[J]. J Med Chem, 2000, 43(2): 177-189. 被引量:1
  • 6Bermack J E, Haddjeri N, Debonnel G, et al. Effects of the potential antidepressant OPC 14523, a combinded sigma and 5-HT1A ligand: modulation of neuronal activity in the dorsal raphe nucleus[J]. J Pharmacol Exp Ther,2004, 310(2):578-583. 被引量:1
  • 7Obrenovitch T P, Zilkha E. Inhibition of cortical spreading depression by L-701,324, a novel antagonist at the glycine site of the N-methyl-D-aspartate receptor complex[J]. Br J Pharmcol, 1996 , 117 (5): 931- 937. 被引量:1
  • 8Schror K. The pharmacology of cilostazol[J]. Diabetes Obes Metab, 2002,4 ( Suppl 2): S 14-19. 被引量:1
  • 9Koga Y, Kihara Y, Okada M, et al. 2(1H)-quinolinone derivatives as novel anti-arteriostenotic agents showing antithrombotic and anti-hyperplastic activities [ J ]. Bioorg Med Chem Lett, 1998, 8(12): 1471-1476. 被引量:1
  • 10Kawasaki K, Komori K, Okazaki J, et al. Inhibition of 12( S )-hydroxyeicosatetraenoic acid ( 12-HETE ) production suppressed the intimal hyperplasia caused by poor-runoff conditions in the rabbit autologous vein grafts [ J]. J Cardiovasc Pharmacol, 2000, 36(5) :555-563. 被引量:1

二级参考文献24

  • 1[1]Song DU et al. Fundam Clin Pharmacol, 1998;12(5) :546~552 被引量:1
  • 2[2]Watanabe S et al. Aliment Pharmacol Ther,1996; 10(6) :927~932 被引量:1
  • 3[3]ArakawaTetal. DigDisSci, 1995; 40(11):2469~2472 被引量:1
  • 4[4]Takaishi O et al. Dig Dis Sci, 1998; 43(Suppl 9) :S78~S82 被引量:1
  • 5[5]Suetsugu H et al. JLabClinMed, 2000; 136(1):50~57 被引量:1
  • 6[6]Tarnawski A et al. Dig Dis Sci, 1998; 43(Suppl 9) :S90~S98 被引量:1
  • 7[7]Hayashi S et al. Antimicrob Agents Chemother,1998; 42(8): 1895~1899 被引量:1
  • 8[8]Kim CD et al. J Pharmacol Exp Ther, 1999; 288(1) :133~138 被引量:1
  • 9[9]Aihara M et al. Dig Dis Sci, 1998; 43(Suppl 9):S174~S180 被引量:1
  • 10[10]Aihara M et al. Dig Dis Sci, 1998; 49(Suppl 9):S160~S166 被引量:1

共引文献19

同被引文献135

引证文献15

二级引证文献70

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部